(Q37335922)

19 August 2017

Lenalidomide for the treatment of resistant discoid lupus erythematosus (English)

1 reference

19 August 2017

Asha Shah

1

1 reference

19 August 2017

Joerg Albrecht

2

1 reference

19 August 2017

Zuleika Bonilla-Martinez

3

1 reference

19 August 2017

Joyce Okawa

4

1 reference

19 August 2017

Mathew Rose

5

1 reference

19 August 2017

Misha Rosenbach

6

1 reference

19 August 2017

Victoria P Werth

7

1 reference

19 August 2017

1 March 2009

1 reference

19 August 2017

Archives of Dermatology

1 reference

19 August 2017

145

1 reference

19 August 2017

3

1 reference

19 August 2017

303-306

1 reference

19 August 2017

Immunomodulatory drugs.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2739109

The CLASI (Cutaneous Lupus Erythematosus Disease Area and Severity Index): an outcome instrument for cutaneous lupus erythematosus

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2739109

Properties of thalidomide and its analogues: implications for anticancer therapy

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2739109

IMiDs: a novel class of immunomodulators

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2739109

Update on the management of cutaneous lupus erythematosus

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2739109

Cutaneous lupus erythematosus: diagnosis and management

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2739109

Thalidomide in cutaneous lupus erythematosus

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2739109

Amino-substituted thalidomide analogs: potent inhibitors of TNF-alpha production

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2739109

Thalidomide selectively inhibits tumor necrosis factor alpha production by stimulated human monocytes

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2739109

Incidence and risk factors for thalidomide neuropathy: a prospective study of 135 dermatologic patients.

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2739109

Chronic cutaneous lupus erythematosus treated with thalidomide

2 September 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/19289762

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1001/ARCHDERMATOL.2009.30

1 reference

release_obln54y5sfgmxdtf6rdimzg75e

19 August 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/obln54y5sfgmxdtf6rdimzg75e

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference

19 August 2017

PubMed publication ID

19289762

1 reference